These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 11264351)

  • 1. Degradation of p21cip1 in cells productively infected with human cytomegalovirus.
    Chen Z; Knutson E; Kurosky A; Albrecht T
    J Virol; 2001 Apr; 75(8):3613-25. PubMed ID: 11264351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ubiquitin/proteasome-dependent degradation of D-type cyclins is linked to tumor necrosis factor-induced cell cycle arrest.
    Hu X; Bryington M; Fisher AB; Liang X; Zhang X; Cui D; Datta I; Zuckerman KS
    J Biol Chem; 2002 May; 277(19):16528-37. PubMed ID: 11864973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination.
    Sheaff RJ; Singer JD; Swanger J; Smitherman M; Roberts JM; Clurman BE
    Mol Cell; 2000 Feb; 5(2):403-10. PubMed ID: 10882081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p21cip1 Degradation in differentiated keratinocytes is abrogated by costabilization with cyclin E induced by human papillomavirus E7.
    Noya F; Chien WM; Broker TR; Chow LT
    J Virol; 2001 Jul; 75(13):6121-34. PubMed ID: 11390614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of the cell cycle inhibitor CIP1/WAF1 in lung alveolar epithelial cell growth arrest induced by glucocorticoids.
    Corroyer S; Nabeyrat E; Clement A
    Endocrinology; 1997 Sep; 138(9):3677-85. PubMed ID: 9275052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experimental study of the effect of human cytomegalovirus infection on cell cycle progression and the expression of cyclins].
    Liu N; Yu YH; Zhong M; Wen LZ
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Jun; 21(2):162-4. PubMed ID: 17653324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteasome inhibitors: a novel tool to suppress human cytomegalovirus replication and virus-induced immune modulation.
    Prösch S; Priemer C; Höflich C; Liebenthaf C; Babel N; Krüger DH; Volk HD
    Antivir Ther; 2003 Dec; 8(6):555-67. PubMed ID: 14760889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells.
    Orend G; Hunter T; Ruoslahti E
    Oncogene; 1998 May; 16(20):2575-83. PubMed ID: 9632134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-beta mediated G1 arrest in a human melanoma cell line lacking p15INK4B: evidence for cooperation between p21Cip1/WAF1 and p27Kip1.
    Flørenes VA; Bhattacharya N; Bani MR; Ben-David Y; Kerbel RS; Slingerland JM
    Oncogene; 1996 Dec; 13(11):2447-57. PubMed ID: 8957087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for involvement of calpain in c-Myc proteolysis in vivo.
    Small GW; Chou TY; Dang CV; Orlowski RZ
    Arch Biochem Biophys; 2002 Apr; 400(2):151-61. PubMed ID: 12054425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human cytomegalovirus infection results in altered Cdk2 subcellular localization.
    Bresnahan WA; Thompson EA; Albrecht T
    J Gen Virol; 1997 Aug; 78 ( Pt 8)():1993-7. PubMed ID: 9266999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
    Coppock DL; Buffolino P; Kopman C; Nathanson L
    Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specificities of cell permeant peptidyl inhibitors for the proteinase activities of mu-calpain and the 20 S proteasome.
    Mellgren RL
    J Biol Chem; 1997 Nov; 272(47):29899-903. PubMed ID: 9368065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction with cyclin-dependent kinases and PCNA modulates proteasome-dependent degradation of p21.
    Cayrol C; Ducommun B
    Oncogene; 1998 Nov; 17(19):2437-44. PubMed ID: 9824154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo ubiquitination and proteasome-mediated degradation of p53(1).
    Maki CG; Huibregtse JM; Howley PM
    Cancer Res; 1996 Jun; 56(11):2649-54. PubMed ID: 8653711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of p27Kip1 in G1 arrest by high dose 5 alpha-dihydrotestosterone in LNCaP human prostate cancer cells.
    Tsihlias J; Zhang W; Bhattacharya N; Flanagan M; Klotz L; Slingerland J
    Oncogene; 2000 Feb; 19(5):670-9. PubMed ID: 10698512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of p21Cip1/Waf1 peptide domains required for cyclin E/Cdk2 and PCNA interaction.
    Chen IT; Akamatsu M; Smith ML; Lung FD; Duba D; Roller PP; Fornace AJ; O'Connor PM
    Oncogene; 1996 Feb; 12(3):595-607. PubMed ID: 8637717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. G1 phase accumulation induced by UCN-01 is associated with dephosphorylation of Rb and CDK2 proteins as well as induction of CDK inhibitor p21/Cip1/WAF1/Sdi1 in p53-mutated human epidermoid carcinoma A431 cells.
    Akiyama T; Yoshida T; Tsujita T; Shimizu M; Mizukami T; Okabe M; Akinaga S
    Cancer Res; 1997 Apr; 57(8):1495-501. PubMed ID: 9108451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway.
    Rousseau D; Cannella D; Boulaire J; Fitzgerald P; Fotedar A; Fotedar R
    Oncogene; 1999 Jul; 18(30):4313-25. PubMed ID: 10439039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deregulation of p53/p21Cip1/Waf1 pathway contributes to polyploidy and apoptosis of E1A+cHa-ras transformed cells after gamma-irradiation.
    Bulavin DV; Tararova ND; Aksenov ND; Pospelov VA; Pospelova TV
    Oncogene; 1999 Oct; 18(41):5611-9. PubMed ID: 10523840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.